21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Entry into mitosis is driven by the phosphorylation of thousands of substrates, under the master control of Cdk1. During entry into mitosis, Cdk1, in collaboration with MASTL kinase, represses the activity of the major mitotic protein phosphatases, PP1 and PP2A, thereby ensuring mitotic substrates remain phosphorylated. For cells to complete and exit mitosis, these phosphorylation events must be removed, and hence, phosphatase activity must be reactivated. This reactivation of phosphatase activity presumably requires the inhibition of MASTL; however, it is not currently understood what deactivates MASTL and how this is achieved. In this study, we identified that PP1 is associated with, and capable of partially dephosphorylating and deactivating, MASTL during mitotic exit. Using mathematical modelling, we were able to confirm that deactivation of MASTL is essential for mitotic exit. Furthermore, small decreases in Cdk1 activity during metaphase are sufficient to initiate the reactivation of PP1, which in turn partially deactivates MASTL to release inhibition of PP2A and, hence, create a feedback loop. This feedback loop drives complete deactivation of MASTL, ensuring a strong switch-like activation of phosphatase activity during mitotic exit.

          Abstract

          Highlighted Article: Our results show that loss of Cdk1 activity allows PP1 to partially dephosphorylate MASTL, activating PP2A, which completes the dephosphorylation and deactivation of MASTL, thereby promoting mitotic exit.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1.

          CDK1 is a nonredundant cyclin-dependent kinase (CDK) with an essential role in mitosis, but its multiple functions still are poorly understood at a molecular level. Here we identify a selective small-molecule inhibitor of CDK1 that reversibly arrests human cells at the G(2)/M border of the cell cycle and allows for effective cell synchronization in early mitosis. Inhibition of CDK1 during cell division revealed that its activity is necessary and sufficient for maintaining the mitotic state of the cells, preventing replication origin licensing and premature cytokinesis. Although CDK1 inhibition for up to 24 h is well tolerated, longer exposure to the inhibitor induces apoptosis in tumor cells, suggesting that selective CDK1 inhibitors may have utility in cancer therapy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance.

            Here we show that the functional human ortholog of Greatwall protein kinase (Gwl) is the microtubule-associated serine/threonine kinase-like protein, MAST-L. This kinase promotes mitotic entry and maintenance in human cells by inhibiting protein phosphatase 2A (PP2A), a phosphatase that dephosphorylates cyclin B-Cdc2 substrates. The complete depletion of Gwl by siRNA arrests human cells in G2. When the levels of this kinase are only partially depleted, however, cells enter into mitosis with multiple defects and fail to inactivate the spindle assembly checkpoint (SAC). The ability of cells to remain arrested in mitosis by the SAC appears to be directly proportional to the amount of Gwl remaining. Thus, when Gwl is only slightly reduced, cells arrest at prometaphase. More complete depletion correlates with the premature dephosphorylation of cyclin B-Cdc2 substrates, inactivation of the SAC, and subsequent exit from mitosis with severe cytokinesis defects. These phenotypes appear to be mediated by PP2A, as they could be rescued by either a double Gwl/PP2A knockdown or by the inhibition of this phosphatase with okadaic acid. These results suggest that the balance between cyclin B-Cdc2 and PP2A must be tightly regulated for correct mitotic entry and exit and that Gwl is crucial for mediating this regulation in somatic human cells.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis.

              Entry into mitosis in eukaryotes requires the activity of cyclin-dependent kinase 1 (Cdk1). Cdk1 is opposed by protein phosphatases in two ways: They inhibit activation of Cdk1 by dephosphorylating the protein kinases Wee1 and Myt1 and the protein phosphatase Cdc25 (key regulators of Cdk1), and they also antagonize Cdk1's own phosphorylation of downstream targets. A particular form of protein phosphatase 2A (PP2A) containing a B55δ subunit (PP2A- B55δ) is the major protein phosphatase that acts on model CDK substrates in Xenopus egg extracts and has antimitotic activity. The activity of PP2A-B55δ is high in interphase and low in mitosis, exactly opposite that of Cdk1. We report that inhibition of PP2A-B55δ results from a small protein, known as α-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55δ. This pathway represents a previously unknown element in the control of mitosis.
                Bookmark

                Author and article information

                Journal
                J Cell Sci
                J. Cell. Sci
                JCS
                joces
                Journal of Cell Science
                The Company of Biologists Ltd
                0021-9533
                1477-9137
                1 April 2016
                1 April 2016
                : 129
                : 7
                : 1340-1354
                Affiliations
                [1 ]The Kinghorn Cancer Centre, Garvan Institute of Medical Research , Darlinghurst, New South Wales 2010, Australia
                [2 ]Systems Biology Ireland, University College Dublin , Dublin 4, Ireland
                [3 ]The Charles Perkins Centre, School of Molecular Bioscience and Sydney Medical School, The University of Sydney , Sydney, New South Wales 2006, Australia
                [4 ]School of Chemistry, The University of Sydney , Sydney 2006, New South Wales, Australia
                [5 ]Department of Biochemistry and Molecular Biology, School of Biomedical Sciences Monash University , Clayton, Victoria 3800, Australia
                [6 ]St. Vincent's Clinical School , Faculty of Medicine, UNSW , Darlinghurst 2010, New South Wales, Australia
                [7 ]Department of Thoracic Medicine, St Vincent's Hospital , Darlinghurst, New South Wales 2010, Australia
                Author notes
                [* ]Author for correspondence ( a.burgess@ 123456garvan.org.au )
                Article
                JCS179754
                10.1242/jcs.179754
                4852720
                26872783
                e20dbc6b-beaf-43d7-8718-6aaaf691aad2
                © 2016. Published by The Company of Biologists Ltd

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

                History
                : 31 August 2015
                : 8 February 2016
                Funding
                Funded by: Cancer Institute NSW, http://dx.doi.org/10.13039/501100001171;
                Award ID: 10/FRL/3-02
                Funded by: The Patricia Helen Guest Fellowship;
                Funded by: Petre Foundation, http://dx.doi.org/10.13039/501100002337;
                Categories
                Research Article

                Cell biology
                mitotic exit,greatwall,mastl,pp1,pp2a,cdk1,kinase,phosphatase,bistable switch
                Cell biology
                mitotic exit, greatwall, mastl, pp1, pp2a, cdk1, kinase, phosphatase, bistable switch

                Comments

                Comment on this article